| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Zentalis Pharmaceuticals, Inc. (ZNTL) has 6 insiders with recent SEC Form 4 filings, including 3 buys and 10 sells. ZNTL is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 13.51M | $49.58M | - | |
| 10% | 6.46M | $23.71M | - | |
| Other | 146.5K | $537.7K | - | |
| Other | 100.0K | $367.0K | - | |
| CEO | 79.1K | $290.4K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb 2, 2024 | Paul Andrea | Chief Legal Officer | Sell | 3,310 | $11.54 | $38,197.40 | -2.2% | -4.1% | -85.0% | |
| Feb 2, 2024 | Gallagher Cam81 | President | Sell | 11,552 | $11.54 | $133,310.08 | -1.8% | -4.1% | -85.0% | |
| Feb 2, 2024 | Epperly Melissa B,72 | Chief Financial Officer | Sell | 8,669 | $11.54 | $100,040.26 | -1.9% | -4.1% | -85.0% | |
| Nov 13, 2023 | Blackwell Kimberly75 | Chief Executive Officer | Buy | 5,000 | $10.29 | $51,448.00 | +2.0% | +12.1% | -63.8% | |
| Nov 10, 2023 | Johnson David Michael59 | Director | Buy | 17,000 | $9.88 | $167,943.00 | +13.3% | +17.3% | -59.8% | |
| Oct 4, 2023 | Brownstein Carrie | Chief Medical Officer | Sell | 10,628 | $19.50 | $207,297.77 | -4.8% | -19.7% | -83.9% | |
| Oct 4, 2023 | Bunker Kevin D.78 | Chief Scientific Officer | Sell | 6,068 | $19.50 | $118,355.48 | -0.4% | -19.7% | -83.9% | |
| Oct 4, 2023 | Epperly Melissa B,72 | Chief Financial Officer | Sell | 5,482 | $19.50 | $106,925.60 | -0.7% | -19.7% | -83.9% | |
| Sep 11, 2023 | Skvarka Jan | Director | Sell | 5,000 | $25.05 | $125,237.50 | -9.4% | -48.7% | -86.9% | |
| Jun 20, 2023 | Matrix Capital Management Company, LP | 10% Owner | Buy | 4,760,000 | $22.66 | $107,861,600.00 | +51.7% | -21.1% | -81.6% |